Complete disregard for patient safety
One star only because zero isn’t an option. I paid hundreds of pounds for medication that arrived open on 19 August. I reported this immediately and was told it was “unlikely” to have been tampered with and was therefore considered safe to use. “Unlikely” is hardly a reassuring or acceptable standard when dealing with medication and patient safety. The packaging was clearly inadequate to protect the contents. I was subsequently sent a series of apologetic emails promising that the matter would be investigated and resolved within three days. That deadline was missed by more than two weeks. After repeated assurances that a full and thorough investigation was taking place, I have now been told to complete yet another form, which will apparently be passed to the “management team”, who will respond within a further 2–3 weeks. So what exactly has been happening for the past fortnight? The communication has been poor, the promises have not been followed through, and, most concerningly, I have been advised that medication which arrived open is probably safe to use. On what planet is that considered an acceptable approach to patient safety, customer care or professional standards? This is not simply poor customer service. It demonstrates a deeply concerning disregard for the potential risks involved when supplying medication. Customers should not be expected to take a chance with their health because a company cannot provide secure packaging, timely responses or a satisfactory investigation. I find the entire handling of this matter outrageous and completely unacceptable. I will now be referring the matter to Trading Standards, the General Pharmaceutical Council (GPhC) and the Medicines and Healthcare products Regulatory Agency (MHRA) for consideration. I would strongly advise others to think very carefully before using this company.
